GlassScriptPhysician profile
Christopher P Hayes
NPI 1578770756
$4,786.06
in general payments reported to CMS, 2019-2025
45 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $195 · 2021: $814 · 2022: $1,079 · 2023: $834 · 2024: $501 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,822 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.37 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $896.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $566.69 | 2021-2023 | |
| Amgen INC. | $416.74 | 2019-2025 | Evenity, Repatha, Prolia |
| Abbott Laboratories | $388.16 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $321.88 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $279.47 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $227.07 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Qol Medical, LLC | $223.59 | 2019-2025 | Sucraid, Sucraid |
| Exact Sciences Corporation | $149.87 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.02 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $96.51 | 2019-2022 | |
| Astellas Pharma US INC | $80.54 | 2019-2020 | |
| Esperion Therapeutics, INC. | $79.46 | 2021-2022 | |
| Edwards Lifesciences Corporation | $71.40 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceutical Holding Company LTD. | $71.24 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.